Old Web
English
Sign In
Acemap
>
authorDetail
>
A.J.A. Woolford
A.J.A. Woolford
Chemistry
Lipoprotein-associated phospholipase A2
Biochemistry
Cancer research
cancer cell lines
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The clinical candidate, ASTX029, is a novel, dual mechanism ERK1/2 inhibitor and has potent activity in MAPK-activated cancer cell lines and in vivo tumor models
2020
European Journal of Cancer
J. Munck
V. Berdini
Aurélie Courtin
C East
T. Heightman
C Hindley
J. Kucia-Tran
John Lyons
V. Martins
S. Muench
Christopher W. Murray
D Norton
M. O'Reilly
M. Reader
David C. Rees
Sharna J. Rich
N. Thompson
N.E. Wilsher
A.J.A. Woolford
Nicola G. Wallis
Show All
Source
Cite
Save
Citations (0)
Fragment-based inhibitors of Lipoprotein associated Phospholipase A2
2016
A.J.A. Woolford
P. J. Day
Show All
Source
Cite
Save
Citations (0)
Compound binding to Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)discovered through fragment screening
2016
P. J. Day
A.J.A. Woolford
Show All
Source
Cite
Save
Citations (0)
1